Related Experiment Videos
Management of hypertension in the diabetic patient
1Department of Allergy and Immunology, University of Wisconsin Hospital and Clinics, Madison 53705.
Insights
Managing hypertension in diabetes is crucial for preventing cardiovascular disease and microvascular complications. Angiotensin-converting-enzyme inhibitors and calcium-channel blockers are preferred initial treatments for hypertensive diabetics.
Area of Science:
- Cardiology
- Endocrinology
- Pharmacology
Background:
- Hypertension is a significant risk factor for cardiovascular disease and microvascular complications in diabetic patients.
- Effective blood pressure control is vital to mitigate morbidity and mortality associated with diabetes and hypertension.
- Hypertension can exacerbate diabetic complications such as nephropathy and retinopathy.
Purpose of the Study:
- To review therapeutic considerations for treating hypertension in patients with diabetes mellitus.
- To evaluate the safety and efficacy of various antihypertensive drug classes in diabetic individuals.
- To provide guidance on selecting appropriate antihypertensive agents for diabetic patients.
Main Methods:
- Review of existing literature on hypertension management in diabetes mellitus.
- Analysis of the effects of different antihypertensive drug classes on metabolic parameters and diabetic complications.
- Comparison of traditional antihypertensive therapies with newer agents in the context of diabetes.
Main Results:
- Traditional agents like diuretics and beta-blockers may have adverse metabolic effects and are not ideal initial choices for diabetics.
- Calcium-channel blockers are generally safe and well-tolerated in diabetic patients at appropriate doses.
- Angiotensin-converting-enzyme inhibitors demonstrate a nephroprotective effect by slowing diabetic nephropathy progression.
Conclusions:
- Angiotensin-converting-enzyme inhibitors and calcium-channel blockers are recommended as first-line agents for mild hypertension in diabetic patients.
- Diuretics and beta-blockers may be used, but their metabolic side effects require careful consideration.
- Treatment of severe or resistant hypertension in diabetics often necessitates combination therapy, including a diuretic, with individualized patient monitoring.
Abstract:
Therapeutic considerations regarding the treatment of hypertension in patients with diabetes mellitus are reviewed. Good blood pressure control is essential in diabetic patients to prevent morbidity and mortality associated with cardiovascular diseases. Hypertension may also accelerate complications of diabetic microvascular disease, nephropathy, and retinopathy. Diuretics (e.g., thiazides, furosemide, ethacrynic acid, bumetanide) and beta blockers have traditionally been used as initial therapy for most patients with hypertension; however, these agents may not be the best choice for diabetics. Adverse metabolic consequences include alteration of glucose metabolism and plasma lipids. Beta blockers may also blunt the ability of patients to recognize symptoms of hypoglycemia. Both diuretics and beta blockers can cause sexual dysfunction in men. Adrenergic agents and vasodilators are associated with a high prevalence of orthostatic hypotension in diabetic patients. The calcium-channel blockers are considered safe and well tolerated when given at low and moderate doses. The angiotensin-converting-enzyme (ACE) inhibitors are able to slow the progression of diabetic nephropathy by reducing the glomerular hypertension that causes it. For the treatment of mild hypertension in diabetic patients, the drugs of choice should include (in descending order) ACE inhibitors, calcium-channel blockers, diuretics, and beta blockers. Severe or resistant hypertension usually requires treatment with combinations of drugs, including a diuretic. Tailoring therapy to individual complications and close monitoring of the patient are essential for safe, effective treatment of hypertension in the diabetic patient.